WBC-containing allogeneic blood transfusion and mortality: A meta-analysis of randomized controlled trials

Transfusion

Volumn 43, Issue 7, 2003, Pages 963-973

  Vamvakas, Eleftherios C ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; HUMAN; IMMUNOMODULATION; LEUKOCYTE; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; OPEN HEART SURGERY; RANDOMIZED CONTROLLED TRIAL; VASCULAR SURGERY;

BLOOD COMPONENT REMOVAL; BLOOD TRANSFUSION, AUTOLOGOUS; CARDIAC SURGICAL PROCEDURES; COLORECTAL NEOPLASMS; ERYTHROCYTE TRANSFUSION; HIV SEROPOSITIVITY; HUMANS; LEUKOCYTES; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS; TRANSPLANTATION, HOMOLOGOUS; VASCULAR SURGICAL PROCEDURES;

EID: 0037631614     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00426.x     Document Type: Article

References (71)

1. Silliman CC, Clay KL, Thurman GW, et al. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994;124:684-94.
2. Zallen G, Moore EE, Ciesla DJ, et al. Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2. Shock 2000;13:29-33.
3. Silliman CC, Hiester AA. Plasma from stored red cells activates human pulmonary endothelial cells. Transfusion 1998;38 Suppl:96S.
4. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998;101:1458-67.
5. Chin-Yee I, Keeney M, Krueger L, et al. Supernatant from stored red cells activates neutrophils. Transfus Med 1998;8:49-56.
6. Zallen G, Offner PJ, Moore EE, et al. Age of transfused blood is an independent risk factor for postinjury multiple-organ failure. Am J Surg 1999;178:570-2.
7. Johnson JL, Moore EE, Offner PJ, et al. Resuscitation with a blood substitute abrogates pathologic postinjury neutrophil cytotoxic function. J Trauma 2001;50:449-55.
8. Hachida M, Hanayama N, Okamura T, et al. The role of leukocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass. ASAIO J 1995;41:M291-4.
9. Gu YJ, de Vries AJ, Boonstra PW, et al. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 1996;112:494-500.
10. Pearl JM, Drinkwater DC, Laks H, et al. Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury. J Surg Res 1992;52:298-308.
11. Fransen E, Maessen J, Dentener M, et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999;116:1233-9.
12. Habib RH, Zacharias A, Engoren M. Determinants of prolonged mechanical ventilation after coronary artery bypass grafting. Ann Thorac Surg 1996;62:1164-71,
13. Vamvakas EC, Carven JH. Allogeneic blood transfusion and postoperative duration of mechanical ventilation: effects of red cell supernatant, platelet supernatant, plasma components, and total transfused fluid. Vox Sang 2002;82:141-9.
14. Maetani S, Nishikawa T, Tobe T, Hirakawa A. Role of blood transfusion in organ system failure following major abdominal surgery. Ann Surg 1986;203:275-81.
15. Sauaia A, Moore FA, Moore EE, et al. Early predictors of postinjury multiple-organ failure. Arch Surg 1994;129:39-45.
16. Trann DD, Van Onselen EB, Wensink AJ, Cuesta MA. Factors related to multiple organ system failure and mortality in a surgical intensive care unit. Nephrol Dial Transplant 1994;9 Suppl 4:172S-8S.
17. Peerless JR, Alexander J, Pinchak AC, et al. Oxygen delivery is an important predictor of outcome in patients with ruptured aortic aneurysms. Ann Surg 1998;227:726-32.
18. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002;288:1499-507.
19. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple-organ failure. Surg Clin North Am 1995;75:257-77.
20. Vedder NB, Fouty BW, Winn RK, Harlan JM. Role of neutrophils in generalized reperfusion injury associated with resuscitation from shock. Surgery 1989;106:509-16.
21. Anderson BO, Harken AH. Multiple-organ failure: inflammatory priming and activation sequences promote autologous tissue injury. J Trauma 1990;30(12 Suppl):S44-9.
22. Botha AJ, Moore FA, Moore EE, et al. Postinjury neutrophil priming and activation states: therapeutic challenges. Shock 1995;3:157-66.
23. Santamaria F, Villa MP, Werner B, et al. The effect of transfusion on pulmonary function in patients with thalassemia major. Pediatr Pulmonol 1994;18:139-43.
24. Hébert PC, Blajchman MA, Cook DJ, et al. Do blood transfusions improve outcomes related to mechanical ventilation? Chest 2001;119:1850-7.
25. Blumberg N, Heal JM. Effects of transfusion on immune function: cancer recurrence and infection. Arch Pathol Lab Med 1994;118:371-9.
26. van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998;97:562-8.
27. Bilgin YM, van de Watering LM, Lorinser JE, et al. The effects of prestorage leukocyte-depletion of erythrocyte concentrates in cardiac surgery: a double-blind randomized clinical trial. Blood 2001;98:828a-9a.
28. Bilgin YM, van de Watering LM, Lorinser JE, et al. Leukocyte-depletion in cardiac surgery lowers postoperative infection but not multiple-organ dysfunction syndrome: results of a clinical study. Vox Sang 2002;83 Suppl 2:225.
29. van Hilten JA, Brand A. A multi-center prospective randomized trial of buffy-coat-depleted- and leukocyte-filtered erythrocyte transfusions in vascular- and gastrointestinal oncologic surgery. Vox Sang 2002;83 Suppl 1:453-6.
30. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372-6.
31. Houbiers JG, Brand A, van de Watering LM, et al. Randomised controlled trial comparing transfusion of leukocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994;344:573-8.
32. Heiss MM, Mempel W, Delanoff C, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859-67.
33. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-6.
34. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993;342:1328-33.
35. Jensen LS, Kissmeyer-Nielsen P, Wolff B, et al. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996;348:841-5.
36. Tartter PI, Mohandas K, Azar P, et al. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998;176:462-6.
37. Collier A, Kalish L, Busch M, et al. Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection. JAMA 2001;285:1592-601.
38. Dzik WH, Anderson JK, O'Neill EM, et al. A prospective, randomized clinical trial of universal WBC reduction. Transfusion 2002;42:1114-22.
39. Lachin JM. Statistical properties of randomization in clinical trials. Control Clin Trials 1988;9:289-311.
40. van de Watering LM, Brand A, Houbiers JG, et al. Perioperative blood transfusions, with or without allogeneic leukocytes, relate to survival, not to cancer recurrence. Br J Surg 2001;88:267-72.
41. Farrer A, Spark JI, Scott DJ. Autologous blood transfusion: the benefits for the patient undergoing abdominal aortic aneurysm repair. J Vasc Nurs 1997;15:111-5.
42. Nielsen HJ, Hammer JH, Kraup AL, et al. Prestorage leukocyte filtration may reduce leukocyte-derived bioactive substance accumulation in patients operated for burn trauma. Burns 1999;25:162-70.
43. Titlestad IL, Ebbesen LS, Ainsworth AP, et al. Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications: results of a double-blinded, randomized study. Int J Colorectal Dis 2001;16:147-53.
44. Wong JC, Torella F, Haynes SL, et al. Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial. Ann Surg 2002;235:145-51.
45. Wallis JP, Chapman CE, Orr KE, Clark S, Forty J. Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 2002;42:1127-34.
46. Perttila JT, Salo MS, Jalonen JR, et al. Blood transfusion with autologous and leukocyte-depleted or standard allogeneic red blood cells and the immune response to open-heart surgery. Anesth Analg 1994;79:654-60.
47. Newman JH, Bowers M, Murphy J. The clinical advantages of autologous transfusion: a randomized, controlled study after knee replacement. J Bone Joint Surg Br 1997;79:630-2.
48. Thomas D, Wareham K, Cohen D, Hutchings H. Autologous blood transfusion in total knee replacement surgery. Br J Anaesth 2001;86:669-73.
49. Spark JI, Chetter IC, Kester RC, Scott DJ. Allogeneic versus autologous blood during abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 1997;14:482-6.
50. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
51. Cooper H, Hedges LV (editors). The handbook of research synthesis. New York: Russell Sage Foundation; 1994.
52. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703-21.
53. Kao KJ. Induction of humoral immune tolerance to major histocompatibility complex antigens by transfusions of UVB-irradiated leukocytes. Blood 1996;88:4375-82.
54. Nielsen HJ, Reimert CM, Pedersen AN, et al. Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 1996;36:960-5.
55. Ghio M, Contini P, Mazzei C, et al. Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusion. Blood 1999;93:1770-7.
56. Magee CC, Sayegh MH. Peptide-mediated immunosuppression. Curr Opin Immunol 1997;9:669-75.
57. Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995;82:582-7.
58. Casagrande JT, Pike MC. An improved approximate formula for calculating sample sizes for comparing binomial distributions. Biometrics 1978;34:483-6.
59. May GS, DeMets DL, Friedman LM, et al. The randomized clinical trial: bias in the analysis. Circulation 1981;64:669-73.
60. Felson DT. Bias in meta-analytic research. J Clin Epidemiol 1992;45:885-92.
61. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991;337:867-72.
62. Villar J, Carroli G, Belizan JM. Predictive ability of meta-analyses of randomised controlled trials. Lancet 1995;345:772-6.
63. Cappelleri JC, Ioannidis JP, Schmid CH, et al. Large trials vs. meta-analyses of small trials: how do their results compare? JAMA 1996;276:1332-8.
64. LeLorier J, Grégoire B, Benhaddad A, et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997;337:536-42.
65. Ioannidis JP, Cappelleri JC, Lau J. Issues in comparisons between meta-analyses and large trials. JAMA 1998;279:1089-93.
66. Bracey AW, Radovancevik R, Nussmeier NA, et al. Leukocyte-reduced blood in open-heart surgery patients: effects on outcome. Transfusion 2002;42 Suppl:5S.
67. Lau J, Schmid CH, Chalmers TC. Cumulative meta-analysis of clinical trials builds evidence for exemplary meta-analysis. J Clin Epidemiol 1995;48:45-57.
68. Vamvakas EC, Blajchman MA. Universal WBC reduction: the case for and against. Transfusion 2001;41:691-712.
69. Ratko TA, Cummings JP, Oberman HA, et al. Evidence-based recommendations for the use of WBC-reduced cellular blood components. Transfusion 2001;41:1310-9.
70. Nightingale SD. Universal WBC reduction. Transfusion 2001;41:1306-9.
71. Blumberg N, Heal JM, Cowles JW, et al. Leukocyte-reduced transfusions in cardiac surgery. Am J Clin Pathol 2002;118:376-81.